453 related articles for article (PubMed ID: 30375404)
1. Cardiomyocyte gene programs encoding morphological and functional signatures in cardiac hypertrophy and failure.
Nomura S; Satoh M; Fujita T; Higo T; Sumida T; Ko T; Yamaguchi T; Tobita T; Naito AT; Ito M; Fujita K; Harada M; Toko H; Kobayashi Y; Ito K; Takimoto E; Akazawa H; Morita H; Aburatani H; Komuro I
Nat Commun; 2018 Oct; 9(1):4435. PubMed ID: 30375404
[TBL] [Abstract][Full Text] [Related]
2. The alteration of protein prenylation induces cardiomyocyte hypertrophy through Rheb-mTORC1 signalling and leads to chronic heart failure.
Xu N; Guan S; Chen Z; Yu Y; Xie J; Pan FY; Zhao NW; Liu L; Yang ZZ; Gao X; Xu B; Li CJ
J Pathol; 2015 Apr; 235(5):672-85. PubMed ID: 25385233
[TBL] [Abstract][Full Text] [Related]
3. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy.
Liu L; An X; Li Z; Song Y; Li L; Zuo S; Liu N; Yang G; Wang H; Cheng X; Zhang Y; Yang X; Wang J
Cardiovasc Res; 2016 Jul; 111(1):56-65. PubMed ID: 27084844
[TBL] [Abstract][Full Text] [Related]
4. p53 regulates the cardiac transcriptome.
Mak TW; Hauck L; Grothe D; Billia F
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2331-2336. PubMed ID: 28193895
[TBL] [Abstract][Full Text] [Related]
5. Cardiomyocyte-specific ablation of CD36 accelerates the progression from compensated cardiac hypertrophy to heart failure.
Sung MM; Byrne NJ; Kim TT; Levasseur J; Masson G; Boisvenue JJ; Febbraio M; Dyck JR
Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H552-H560. PubMed ID: 28062415
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyocyte BRAF and type 1 RAF inhibitors promote cardiomyocyte and cardiac hypertrophy in mice in vivo.
Clerk A; Meijles DN; Hardyman MA; Fuller SJ; Chothani SP; Cull JJ; Cooper STE; Alharbi HO; Vanezis K; Felkin LE; Markou T; Leonard SJ; Shaw SW; Rackham OJL; Cook SA; Glennon PE; Sheppard MN; Sembrat JC; Rojas M; McTiernan CF; Barton PJ; Sugden PH
Biochem J; 2022 Feb; 479(3):401-424. PubMed ID: 35147166
[TBL] [Abstract][Full Text] [Related]
7. Macrophage microRNA-155 promotes cardiac hypertrophy and failure.
Heymans S; Corsten MF; Verhesen W; Carai P; van Leeuwen RE; Custers K; Peters T; Hazebroek M; Stöger L; Wijnands E; Janssen BJ; Creemers EE; Pinto YM; Grimm D; Schürmann N; Vigorito E; Thum T; Stassen F; Yin X; Mayr M; de Windt LJ; Lutgens E; Wouters K; de Winther MP; Zacchigna S; Giacca M; van Bilsen M; Papageorgiou AP; Schroen B
Circulation; 2013 Sep; 128(13):1420-32. PubMed ID: 23956210
[TBL] [Abstract][Full Text] [Related]
8. Acute heart failure with cardiomyocyte atrophy induced in adult mice by ablation of cardiac myosin light chain kinase.
Massengill MT; Ashraf HM; Chowdhury RR; Chrzanowski SM; Kar J; Warren SA; Walter GA; Zeng H; Kang BH; Anderson RH; Moss RL; Kasahara H
Cardiovasc Res; 2016 Jul; 111(1):34-43. PubMed ID: 27025239
[TBL] [Abstract][Full Text] [Related]
9. Single-Cell Reconstruction of Progression Trajectory Reveals Intervention Principles in Pathological Cardiac Hypertrophy.
Ren Z; Yu P; Li D; Li Z; Liao Y; Wang Y; Zhou B; Wang L
Circulation; 2020 May; 141(21):1704-1719. PubMed ID: 32098504
[TBL] [Abstract][Full Text] [Related]
10. Cardiomyocyte d-dopachrome tautomerase protects against heart failure.
Ma Y; Su KN; Pfau D; Rao VS; Wu X; Hu X; Leng L; Du X; Piecychna M; Bedi K; Campbell SG; Eichmann A; Testani JM; Margulies KB; Bucala R; Young LH
JCI Insight; 2019 Sep; 4(17):. PubMed ID: 31484822
[TBL] [Abstract][Full Text] [Related]
11. Mechanosensitive Gene Regulation by Myocardin-Related Transcription Factors Is Required for Cardiomyocyte Integrity in Load-Induced Ventricular Hypertrophy.
Trembley MA; Quijada P; Agullo-Pascual E; Tylock KM; Colpan M; Dirkx RA; Myers JR; Mickelsen DM; de Mesy Bentley K; Rothenberg E; Moravec CS; Alexis JD; Gregorio CC; Dirksen RT; Delmar M; Small EM
Circulation; 2018 Oct; 138(17):1864-1878. PubMed ID: 29716942
[TBL] [Abstract][Full Text] [Related]
12. Runt-related transcription factor 1 (Runx1) aggravates pathological cardiac hypertrophy by promoting p53 expression.
Zhang D; Liang C; Li P; Yang L; Hao Z; Kong L; Tian X; Guo C; Dong J; Zhang Y; Du B
J Cell Mol Med; 2021 Aug; 25(16):7867-7877. PubMed ID: 34190420
[TBL] [Abstract][Full Text] [Related]
13. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart.
Streicher JM; Ren S; Herschman H; Wang Y
Circ Res; 2010 Apr; 106(8):1434-43. PubMed ID: 20339119
[TBL] [Abstract][Full Text] [Related]
14. Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload.
Ahmad F; Singh AP; Tomar D; Rahmani M; Zhang Q; Woodgett JR; Tilley DG; Lal H; Force T
J Mol Cell Cardiol; 2019 May; 130():65-75. PubMed ID: 30928428
[TBL] [Abstract][Full Text] [Related]
15. Cardiomyocyte-enriched protein CIP protects against pathophysiological stresses and regulates cardiac homeostasis.
Huang ZP; Kataoka M; Chen J; Wu G; Ding J; Nie M; Lin Z; Liu J; Hu X; Ma L; Zhou B; Wakimoto H; Zeng C; Kyselovic J; Deng ZL; Seidman CE; Seidman JG; Pu WT; Wang DZ
J Clin Invest; 2015 Nov; 125(11):4122-34. PubMed ID: 26436652
[TBL] [Abstract][Full Text] [Related]
16. miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy.
Oh JG; Watanabe S; Lee A; Gorski PA; Lee P; Jeong D; Liang L; Liang Y; Baccarini A; Sahoo S; Brown BD; Hajjar RJ; Kho C
Circ Res; 2018 Aug; 123(6):673-685. PubMed ID: 30355233
[TBL] [Abstract][Full Text] [Related]
17. Mixed lineage kinase-3 prevents cardiac dysfunction and structural remodeling with pressure overload.
Calamaras TD; Baumgartner RA; Aronovitz MJ; McLaughlin AL; Tam K; Richards DA; Cooper CW; Li N; Baur WE; Qiao X; Wang GR; Davis RJ; Kapur NK; Karas RH; Blanton RM
Am J Physiol Heart Circ Physiol; 2019 Jan; 316(1):H145-H159. PubMed ID: 30362822
[TBL] [Abstract][Full Text] [Related]
18. RhoGEF12 controls cardiac remodeling by integrating G protein- and integrin-dependent signaling cascades.
Takefuji M; Krüger M; Sivaraj KK; Kaibuchi K; Offermanns S; Wettschureck N
J Exp Med; 2013 Apr; 210(4):665-73. PubMed ID: 23530122
[TBL] [Abstract][Full Text] [Related]
19. BET bromodomain inhibition suppresses innate inflammatory and profibrotic transcriptional networks in heart failure.
Duan Q; McMahon S; Anand P; Shah H; Thomas S; Salunga HT; Huang Y; Zhang R; Sahadevan A; Lemieux ME; Brown JD; Srivastava D; Bradner JE; McKinsey TA; Haldar SM
Sci Transl Med; 2017 May; 9(390):. PubMed ID: 28515341
[TBL] [Abstract][Full Text] [Related]
20. Pressure Overload Greatly Promotes Neonatal Right Ventricular Cardiomyocyte Proliferation: A New Model for the Study of Heart Regeneration.
Ye L; Wang S; Xiao Y; Jiang C; Huang Y; Chen H; Zhang H; Zhang H; Liu J; Xu Z; Hong H
J Am Heart Assoc; 2020 Jun; 9(11):e015574. PubMed ID: 32475201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
